- Home
- ATAI
as 07-09-2025 11:31am EST
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
| Founded: | 2018 | Country: | Germany |
| Employees: | N/A | City: | BERLIN |
| Market Cap: | 444.7M | IPO Year: | 2021 |
| Target Price: | $11.00 | AVG Volume (30 days): | 5.6M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.91 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.03 - $2.98 | Next Earning Date: | 08-12-2025 |
| Revenue: | $1,863,000 | Revenue Growth: | 572.56% |
| Revenue Growth (this year): | 554.22% | Revenue Growth (next year): | -81.02% |
Latest ATAI Life Sciences N.V. News
ATAI Breaking Stock News: Dive into ATAI Ticker-Specific Updates for Smart Investing
Zacks
14 days ago
Are Medical Stocks Lagging atai Life Sciences (ATAI) This Year?
Insider Monkey
15 days ago
Maxim Group Maintains a Buy on Atai Life Sciences (ATAI) With a $6 Price Target
TipRanks
20 days ago
Trump Trade: President said to weigh possible U.S. strike against Iran
TipRanks
20 days ago
Psychedelic advocates hopeful Trump administration will support space, STAT says
WSJ
20 days ago
This Illegal Psychedelic Is Hailed as a ‘Revolutionary Breakthrough’
GlobeNewswire
a month ago
atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies
GlobeNewswire
a month ago
atai Life Sciences to Participate in Upcoming Investor Conferences
TipRanks
2 months ago
Phase 2a data for BPL-003 ‘encouraging’ for Atai Life Sciences, says Jefferies
Compare ATAI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ATAI ATAI Life Sciences N.V. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.